Document Detail


Isolated perfusion of pancreas with mitomycin C.
MedLine Citation:
PMID:  1693475     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The current treatment of pancreatic cancer with resection and/or radiation is considered unsatisfactory because of a high incidence of failure and a moderate incidence of complications. A sizable number of these patients present with localized or regional disease. Regional high-dose chemotherapy, such as with isolated perfusion, may offer an alternative therapy with low treatment-related morbidity and mortality and better end results in this group of patients. In an effort to develop such a treatment modality, we evaluated the pharmacokinetics and toxicity of mitomycin C (MMC) during isolated perfusion of pancreas in a canine model. From this study, it appears that a dose of 0.25 mg MMC/kg body weight is most suitable for isolated perfusion of pancreas at 39 degrees C, maintaining flow rate and pressure within physiologic range. Isolated perfusion with a dose of 0.25 mg/kg body weight has very mild short- and long-term toxicities and markedly increases drug delivery to the pancreas, duodenum, and peripancreatic lymph nodes, making it the most suitable dose for possible clinical application.
Authors:
M A Arredondo; B Chaudhuri; R Kar; K A Crist; N R Thomford; P K Chaudhuri
Related Documents :
16461515 - Entrance radiation doses during paediatric cardiac catheterisations performed for diagn...
1416705 - Ionising radiation: are orthopaedic surgeons at risk?
6802215 - Selenium 75-selenofolate metabolism and radiation dosimetry.
6952205 - Specific-locus mutation frequencies in mouse stem-cell spermatogonia at very low radiat...
2883695 - Benzodiazepine pharmacodynamics: evidence for biophase rate limiting mechanisms.
17301465 - The use of spatial dose gradients and probability density function to evaluate the effe...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American journal of surgery     Volume:  159     ISSN:  0002-9610     ISO Abbreviation:  Am. J. Surg.     Publication Date:  1990 Jun 
Date Detail:
Created Date:  1990-07-06     Completed Date:  1990-07-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370473     Medline TA:  Am J Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  569-74     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Medical College of Ohio, Toledo 43699-0008.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amylases / blood
Animals
Blood Glucose / analysis
Chemotherapy, Cancer, Regional Perfusion*
Chromatography, High Pressure Liquid
Dogs
Duodenum / metabolism
Leukocyte Count
Lipase / blood
Lymph Nodes / metabolism
Male
Mitomycin
Mitomycins / administration & dosage*,  pharmacokinetics,  toxicity
Pancreas* / metabolism
Pancreatic Neoplasms / drug therapy
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Mitomycins; 50-07-7/Mitomycin; EC 3.1.1.3/Lipase; EC 3.2.1.-/Amylases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive...
Next Document:  DNA technology.